Chapter/Section Purchase

1 Study Coverage
1.1 Omalizumab for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Omalizumab for Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Subcutaneous Powder For Injection
1.2.3 Subcutaneous Solution (150 mg/mL)
1.2.4 Subcutaneous Solution(75 mg/0.5 mL)
1.3 Market by Application
1.3.1 Global Omalizumab for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Omalizumab for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Omalizumab for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Omalizumab for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Omalizumab for Injection Sales by Region
2.4.1 Global Omalizumab for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Omalizumab for Injection by Region (2023-2028)
2.5 Global Omalizumab for Injection Revenue by Region
2.5.1 Global Omalizumab for Injection Revenue by Region (2017-2022)
2.5.2 Global Omalizumab for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Omalizumab for Injection Sales by Manufacturers
3.1.1 Global Top Omalizumab for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Omalizumab for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Omalizumab for Injection in 2021
3.2 Global Omalizumab for Injection Revenue by Manufacturers
3.2.1 Global Omalizumab for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Omalizumab for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Omalizumab for Injection Revenue in 2021
3.3 Global Omalizumab for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Omalizumab for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Omalizumab for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Omalizumab for Injection Sales by Type
4.1.1 Global Omalizumab for Injection Historical Sales by Type (2017-2022)
4.1.2 Global Omalizumab for Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Omalizumab for Injection Sales Market Share by Type (2017-2028)
4.2 Global Omalizumab for Injection Revenue by Type
4.2.1 Global Omalizumab for Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Omalizumab for Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Omalizumab for Injection Revenue Market Share by Type (2017-2028)
4.3 Global Omalizumab for Injection Price by Type
4.3.1 Global Omalizumab for Injection Price by Type (2017-2022)
4.3.2 Global Omalizumab for Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Omalizumab for Injection Sales by Application
5.1.1 Global Omalizumab for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Omalizumab for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Omalizumab for Injection Sales Market Share by Application (2017-2028)
5.2 Global Omalizumab for Injection Revenue by Application
5.2.1 Global Omalizumab for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Omalizumab for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Omalizumab for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Omalizumab for Injection Price by Application
5.3.1 Global Omalizumab for Injection Price by Application (2017-2022)
5.3.2 Global Omalizumab for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Omalizumab for Injection Market Size by Type
6.1.1 North America Omalizumab for Injection Sales by Type (2017-2028)
6.1.2 North America Omalizumab for Injection Revenue by Type (2017-2028)
6.2 North America Omalizumab for Injection Market Size by Application
6.2.1 North America Omalizumab for Injection Sales by Application (2017-2028)
6.2.2 North America Omalizumab for Injection Revenue by Application (2017-2028)
6.3 North America Omalizumab for Injection Market Size by Country
6.3.1 North America Omalizumab for Injection Sales by Country (2017-2028)
6.3.2 North America Omalizumab for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Omalizumab for Injection Market Size by Type
7.1.1 Europe Omalizumab for Injection Sales by Type (2017-2028)
7.1.2 Europe Omalizumab for Injection Revenue by Type (2017-2028)
7.2 Europe Omalizumab for Injection Market Size by Application
7.2.1 Europe Omalizumab for Injection Sales by Application (2017-2028)
7.2.2 Europe Omalizumab for Injection Revenue by Application (2017-2028)
7.3 Europe Omalizumab for Injection Market Size by Country
7.3.1 Europe Omalizumab for Injection Sales by Country (2017-2028)
7.3.2 Europe Omalizumab for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Omalizumab for Injection Market Size by Type
8.1.1 Asia Pacific Omalizumab for Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Omalizumab for Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Omalizumab for Injection Market Size by Application
8.2.1 Asia Pacific Omalizumab for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Omalizumab for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Omalizumab for Injection Market Size by Region
8.3.1 Asia Pacific Omalizumab for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Omalizumab for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Omalizumab for Injection Market Size by Type
9.1.1 Latin America Omalizumab for Injection Sales by Type (2017-2028)
9.1.2 Latin America Omalizumab for Injection Revenue by Type (2017-2028)
9.2 Latin America Omalizumab for Injection Market Size by Application
9.2.1 Latin America Omalizumab for Injection Sales by Application (2017-2028)
9.2.2 Latin America Omalizumab for Injection Revenue by Application (2017-2028)
9.3 Latin America Omalizumab for Injection Market Size by Country
9.3.1 Latin America Omalizumab for Injection Sales by Country (2017-2028)
9.3.2 Latin America Omalizumab for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Omalizumab for Injection Market Size by Type
10.1.1 Middle East and Africa Omalizumab for Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Omalizumab for Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Omalizumab for Injection Market Size by Application
10.2.1 Middle East and Africa Omalizumab for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Omalizumab for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Omalizumab for Injection Market Size by Country
10.3.1 Middle East and Africa Omalizumab for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Omalizumab for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Omalizumab for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Omalizumab for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Omalizumab for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Omalizumab for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Omalizumab for Injection Industry Chain Analysis
12.2 Omalizumab for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Omalizumab for Injection Production Mode & Process
12.4 Omalizumab for Injection Sales and Marketing
12.4.1 Omalizumab for Injection Sales Channels
12.4.2 Omalizumab for Injection Distributors
12.5 Omalizumab for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Omalizumab for Injection Industry Trends
13.2 Omalizumab for Injection Market Drivers
13.3 Omalizumab for Injection Market Challenges
13.4 Omalizumab for Injection Market Restraints
14 Key Findings in The Global Omalizumab for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer